Lipoxygenase
Read More about this categoryShow Less
Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid. Thre are six LOX isoforms have been found in the humans and mice. 5-Lipoxygenase (5-LOX) is a distinct isoform playing an important role in asthma and inflammation. 5-LOX causes the constriction of bronchioles in response to cysteinyl leukotrienes such as LTC4, thus leading to asthma. 5-LOX also induces neutrophilic inflammation by its recruitment in response to LTB4. 12-Lipoxygenase (12-LOX) is an isoform expressed in epithelial cells and myeloid cells including platelets. 12-LOX can be found in the epithelial cells of the skin. 12-LOX is a potential target for novel anti-platelet therapeutics.15-Lipoxygenase (15-LOX) is expressed in epithelial cells and leukocytes, has different substrate specificity in the humans and mice.15-LOX-1 is a target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
Products Related to Lipoxygenase(264)
- GC4122013(S)-HODE methyl esterCAS: 109837-85-6Purity: >98.00%
13(S)-hydroxyoctadecadienoic acid (13(S)-HODE) is a 15-lipoxygenase metabolite of linoleic acid produced in endothelial cells, leukocytes, and tumor cells.
- GC4122717(R)-Resolvin D1 methyl esterCAS: 937738-64-2Purity: >95.00%
17(R)-Resolvin D1 (17(R)-RvD1) is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte transendothelial migration, the earliest event in acute inflammation, with equipotency to RvD1 (EC50 = ~30 nM).
- GC41230Resolvin D1 methyl esterCAS: 937738-63-1Purity: >97.00%
Resolvin D1-Methylester (RvD1-Methylester) ist der Methylester von Resolvin D1.
- GC41231Resolvin D2 methyl esterCAS: 810668-53-2Purity: >95.00%
Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase.
- GC41232Resolvin D3 methyl esterPurity: >95.00%
Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties.
- GC413225-OxoETE methyl esterCAS: 74785-00-5Purity: >95.00%
5-OxoETE methyl ester is an esterified form of the polyunsaturated keto acid 5-oxoETE.
- GC4140315(S)-HpEDECAS: 145375-41-3Purity: >98.00%
15(S)-HpEDE is a monohydroperoxy polyunsaturated fatty acid produced by the action of 15-lipoxygenase on eicosadienoic acid.
- GC4141515(R)-Lipoxin A4CAS: 171030-11-8Purity: >95.00%
Lipid-derived lipoxins are produced at the site of vascular and mucosal inflammation where they down-regulate polymorphonuclear leukocyte recruitment and function.
- GC4142120-hydroxy Leukotriene B4CAS: 79516-82-8Purity: >97.00%
20-hydroxy LTB4 is a metabolite of LTB4 in human neutrophils.
- GC414246(S)-Lipoxin A4CAS: 94292-80-5Purity: >95.00%
The lipoxins are trihydroxy fatty acids containing a 7,9,11,13-conjugated tetraene.
- GC4152917-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic AcidCAS: 1233715-28-0Purity: >90.00%
17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DHA that is produced endogenously by aspirin-enhanced COX-2 activity.
- GC41531Anacardic Acid TrieneCAS: 103904-73-0Purity: >98.00%
Anacardic acid triene is a polyunsaturated form of anacardic acid that has been found in cashew nut shell liquid.
- GC41649(±)13-HODE cholesteryl esterCAS: 167354-91-8Purity: >98.00%
(±)13-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL.
- GC41666(±)9-HODE cholesteryl esterCAS: 33783-76-5Purity: >98.00%
(±)9-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL.
- GC417701,2,3-Trieicosapentaenoyl-rac-glycerolCAS: 99660-94-3Purity: >98%
1,2,3-Trieicosapentaenoyl-rac-glycerol (EPA-TG) is a glycerol ester of eicosapentaenoic acid, which is an ω-3 fatty acid.
- GC4188212(S)-HETrECAS: 72710-10-2Purity: >98.00%
12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).
- GC4189613(S)-HODE-biotinCAS: 1176496-97-1Purity: >98.00%
13(S)-HODE is the lipoxygenase metabolite of linoleic acid.
- GC4189713(S)-HOTrECAS: 87984-82-5Purity: >98.00%
13(S)-HOTrE is the 15-lipoxygenase (15-LO) product of linolenic acid.
- GC4189813(S)-HOTrE(γ)CAS: 74784-20-6Purity: >98.00%
13(S)-HOTrE(γ) is the 15-LO product of γ-linolenic acid.
- GC4189913(S)-HpOTrECAS: 67597-26-6Purity: >98.00%
13(S)-HpOTrE is a monohydroperoxy polyunsaturated fatty acid produced in soybeans by the action of soybean LO-2 on esterified α-linolenic acid.
- GC4190013(S)-HpOTrE(γ)CAS: 121107-97-9Purity: >98.00%
13(S)-HpOTrE(γ) is a monohydroxy PUFA produced by the action of soybean lipoxygenase-1 (LO-1) on γ-linolenic acid.
- GC4191113-epi-12-oxo Phytodienoic AcidCAS: 71606-07-0Purity: >95.00%
13-epi-12-oxo Phytodienoic acid (13-epi-12-oxo PDA) is a lipoxygenase metabolite of α-linolenic acid in the leaves of green plants such as corn.
- GC4192515(S)-HETE EthanolamideCAS: 161744-53-2Purity: >98.00%
Arachidonoyl ethanolamide was the first endogenous cannabinoid (CB) to be isolated and characterized as an agonist acting on the same receptors (CB1 and CB2) as THC.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC41220 | 13(S)-HODE methyl ester | 109837-85-6 | >98.00% | |
13(S)-hydroxyoctadecadienoic acid (13(S)-HODE) is a 15-lipoxygenase metabolite of linoleic acid produced in endothelial cells, leukocytes, and tumor cells. | ||||
| GC41227 | 17(R)-Resolvin D1 methyl ester | 937738-64-2 | >95.00% | |
17(R)-Resolvin D1 (17(R)-RvD1) is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte transendothelial migration, the earliest event in acute inflammation, with equipotency to RvD1 (EC50 = ~30 nM). | ||||
| GC41230 | Resolvin D1 methyl ester | 937738-63-1 | >97.00% | |
Resolvin D1-Methylester (RvD1-Methylester) ist der Methylester von Resolvin D1. | ||||
| GC41231 | Resolvin D2 methyl ester | 810668-53-2 | >95.00% | |
Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase. | ||||
| GC41232 | Resolvin D3 methyl ester | - | >95.00% | |
Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties. | ||||
| GC41289 | U-75302 | 119477-85-9 | >95.00% | |
U-75302 ist ein starker Inhibitor von Leukotrien B4. | ||||
| GC41322 | 5-OxoETE methyl ester | 74785-00-5 | >95.00% | |
5-OxoETE methyl ester is an esterified form of the polyunsaturated keto acid 5-oxoETE. | ||||
| GC41403 | 15(S)-HpEDE | 145375-41-3 | >98.00% | |
15(S)-HpEDE is a monohydroperoxy polyunsaturated fatty acid produced by the action of 15-lipoxygenase on eicosadienoic acid. | ||||
| GC41415 | 15(R)-Lipoxin A4 | 171030-11-8 | >95.00% | |
Lipid-derived lipoxins are produced at the site of vascular and mucosal inflammation where they down-regulate polymorphonuclear leukocyte recruitment and function. | ||||
| GC41421 | 20-hydroxy Leukotriene B4 | 79516-82-8 | >97.00% | |
20-hydroxy LTB4 is a metabolite of LTB4 in human neutrophils. | ||||
| GC41424 | 6(S)-Lipoxin A4 | 94292-80-5 | >95.00% | |
The lipoxins are trihydroxy fatty acids containing a 7,9,11,13-conjugated tetraene. | ||||
| GC41529 | 17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid | 1233715-28-0 | >90.00% | |
17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DHA that is produced endogenously by aspirin-enhanced COX-2 activity. | ||||
| GC41531 | Anacardic Acid Triene | 103904-73-0 | >98.00% | |
Anacardic acid triene is a polyunsaturated form of anacardic acid that has been found in cashew nut shell liquid. | ||||
| GC41649 | (±)13-HODE cholesteryl ester | 167354-91-8 | >98.00% | |
(±)13-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL. | ||||
| GC41666 | (±)9-HODE cholesteryl ester | 33783-76-5 | >98.00% | |
(±)9-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL. | ||||
| GC41770 | 1,2,3-Trieicosapentaenoyl-rac-glycerol | 99660-94-3 | >98% | |
1,2,3-Trieicosapentaenoyl-rac-glycerol (EPA-TG) is a glycerol ester of eicosapentaenoic acid, which is an ω-3 fatty acid. | ||||
| GC41882 | 12(S)-HETrE | 72710-10-2 | >98.00% | |
12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA). | ||||
| GC41896 | 13(S)-HODE-biotin | 1176496-97-1 | >98.00% | |
13(S)-HODE is the lipoxygenase metabolite of linoleic acid. | ||||
| GC41897 | 13(S)-HOTrE | 87984-82-5 | >98.00% | |
13(S)-HOTrE is the 15-lipoxygenase (15-LO) product of linolenic acid. | ||||
| GC41898 | 13(S)-HOTrE(γ) | 74784-20-6 | >98.00% | |
13(S)-HOTrE(γ) is the 15-LO product of γ-linolenic acid. | ||||
| GC41899 | 13(S)-HpOTrE | 67597-26-6 | >98.00% | |
13(S)-HpOTrE is a monohydroperoxy polyunsaturated fatty acid produced in soybeans by the action of soybean LO-2 on esterified α-linolenic acid. | ||||
| GC41900 | 13(S)-HpOTrE(γ) | 121107-97-9 | >98.00% | |
13(S)-HpOTrE(γ) is a monohydroxy PUFA produced by the action of soybean lipoxygenase-1 (LO-1) on γ-linolenic acid. | ||||
| GC41911 | 13-epi-12-oxo Phytodienoic Acid | 71606-07-0 | >95.00% | |
13-epi-12-oxo Phytodienoic acid (13-epi-12-oxo PDA) is a lipoxygenase metabolite of α-linolenic acid in the leaves of green plants such as corn. | ||||
| GC41925 | 15(S)-HETE Ethanolamide | 161744-53-2 | >98.00% | |
Arachidonoyl ethanolamide was the first endogenous cannabinoid (CB) to be isolated and characterized as an agonist acting on the same receptors (CB1 and CB2) as THC. | ||||
